ALDH cells demonstrated greater endometrial cancer stem cell activity than CD133+ cells and had increased expression of stem cell and epithelial–mesenchymal transition genes, showing higher prognostic potential [63]. The gene discussed is PROM1; the disease is endometrial cancer.